Clinical Trials

PPD Acquires Patient Recruitment and Retention Firm Acurian

WILMINGTON, N.C.--(BUSINESS WIRE)-- Pharmaceutical Product Development, LLC (PPD) today announced it has acquired Acurian, a leading full-service provider of clinical trial patient enrollment and retention solutions for the life sciences industry.
“As the biopharmaceutical industry continues to face increasing challenges with the time and cost of drug development, PPD is committed to bringing innovation to the clinical development process to deliver efficiencies for our customers,” David Simmons, chairman an

ISPE Surveying Patients on Clinical Trial Materials

ISPE, the International Society for Pharmaceutical Engineering, reports that it is surveying patients globally on their experiences with clinical trial materials. The goal is to gather feedback on the suitability of clinical trial packaging, label information and design, interacting with clinical trial technologies, and transportation and storage, ISPE reports in a press release. With a target of 2000 or more patients from around the world, this study is the first known of its kind in size and scope, it reports.

Standardizing Labeling

ISPE seeks to improve clinical trial personnel understanding and practitioner patient compliance through standardized booklet labels.

ISPE (www.ispe.org) has developed industry guidance to help companies conducting global clinical trials standardize booklet labels. Available for purchase on the group’s Web site (http://www.ispe.org/ispe-good-practice-guides/booklet-labels), the ISPE Good Practice Guide: Booklet Labels was developed to help train clinical trial personnel on proper booklet label use.

Your rating: None Average: 5 (1 vote)

Building Trial Adherence With Packaging

As the cost of running clinical trials climbs, compliance formats have gained favor for addressing persistently high non-adherence rates.
Patient non-adherence is a prevalent concern in clinical trials and one reason why clinical trial costs are on the rise.
No votes yet

Immunotech Laboratories Attains Funding Partner on HIV Treatment Trials

The pharmaceutical development firm has received backing to conduct U.S. clinical trials for various HIV treatments.

Immunotech Laboratories, Inc. today announced the company has been in negotiations with an International Bio-Tech Partner in the HIV cure technology sector for joint advanced Research & Development and the partner has agreed to provide the necessary funding for the USA Clinical Trials phases to ultimately achieve FDA approval for the medicines.

Your rating: None Average: 5 (1 vote)

Lilly Releases Study on Back Pain Treatment in Postmenopausal Women

In the study, the company's FORTEO injection showed positive results in managing patients' pain.

Eli Lilly and Co. today announced data from a Phase III trial comparing the effects of FORTEO (teriparatide [rDNA origin] injection) and risedronate on back pain in postmenopausal women with osteoporotic vertebral fractures.

No votes yet

Ventus Reports Favorable Results in Snoring Treatment Trial

According to the company’s clinical trial data, Theravent has shown positive results in reducing the volume and duration of snoring in patients.

Ventus Medical announces the publication of clinical trial data for its new Theravent Advanced Nightly Snore Therapy in Sleep Diagnosis and Therapy, a medical journal for sleep professionals.

No votes yet

Advaxis ADXS-PSA Shown to Reduce Tumors in Preclinical Prostate Cancer Study

The company's latest immunotherapy has shown positive results in the latest study.

Advaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced the publication of preclinical research with ADXS-PSA (ADXS31-142), Advaxis’ Lm-LLO immunotherapy targeting the PSA antigen associated with prostate cancer.

No votes yet

Report: Record Number of Diabetes Clinical Trials in the Pipeline

Research firm Profil Institute reports burgeoning demand for clinical drug trials.

Profil Institute for Clinical Research, Inc., a company focused on early phase clinical trials for diabetes and obesity, announced today record growth in the number of clinical trials in the pipeline.  Profil Institute also reports an increase in the number of mid-size biotech and off-shore clients, while maintaining active collaborations with the largest global pharmaceutical companies, driven by a strong demand for Phase I and metabolic disease specialization. 

No votes yet

Critical Aspects of Clinical Trial Packaging

Packaging service and technology providers support stringent trial needs with unit-dose packaging, cold-chain support.

By Marie Redding
Freelance Writer

Not much changes very often, or very quickly, in the world of pharmaceuticals—or in regards to packaging for clinical trials—but there are a few trends.

“In the past, we were mainly focused on clinical trials for solid-dose drugs,” says Manfred Zurkirch, CEO, Körber Medipak/Dividella. “In recent years, however, more injectable liquids are being tested,” he says.

No votes yet
Syndicate content